Søgeresultater - Dominic Smethurst
- Showing 1 - 4 results of 4
-
1
First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: A Phase I/II open-la... af George D. Demetri, Axel Le Cesne, Sant P. Chawla, Thomas Brodowicz, Robert G. Maki, Bruce Allen Bach, Dominic Smethurst, Sarah Bray, Yong-Jiang Hei, Jean‐Yves Blay
Udgivet 2012Artigo -
2
Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer af Jean‐Charles Soria, Z. Mark, Petr Zatloukal, B. Szima, István Albert, Erzsébet Juhász, Jean-Louis Pujol, Jerzy Kozielski, Nigel Baker, Dominic Smethurst, Yong‐jiang Hei, Avi Ashkenazi, Howard M. Stern, Lukas C. Amler, Yang Pan, Fiona Blackhall
Udgivet 2011Artigo -
3
Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type <i>KRAS</i> Metastatic Colorectal Cancer af Eric Van Cutsem, Cathy Eng, Elżbieta Nowara, Anna Świeboda-Sadlej, Niall C. Tebbutt, Edith P. Mitchell, Ірина Давиденко, Joe Stephenson, Elena Élez, Hans Prenen, Hongjie Deng, Rui Tang, Ian McCaffery, Kelly S. Oliner, Lisa Chen, Jennifer Gansert, Elwyn Loh, Dominic Smethurst, Josep Tabernero
Udgivet 2014Artigo -
4
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma af Gerald P. Linette, Edward A. Stadtmauer, Marcela V. Maus, Aaron P. Rapoport, Bruce L. Levine, Lyndsey Emery, Leslie A. Litzky, Adam Bagg, Beatriz M. Carreno, Patrick J. Cimino, Gwendolyn Binder-Scholl, Dominic Smethurst, Andrew B. Gerry, Nick Pumphrey, Alan Bennett, Joanna E. Brewer, Joseph Dukes, Jane Harper, Helen K. Tayton-Martin, Bent K. Jakobsen, Namir J. Hassan, Michael Kalos, Carl H. June
Udgivet 2013Artigo
Søgeredskaber:
Relaterede emner
Medicine
Internal medicine
Alternative medicine
Cancer
Chemotherapy
Clinical endpoint
Neutropenia
Oncology
Pathology
Placebo
Surgery
A549 cell
Adverse effect
Anemia
Bevacizumab
Biology
Cancer research
Carboplatin
Cell biology
Cetuximab
Cisplatin
Clinical trial
Colorectal cancer
Doxorubicin
Epidermal growth factor receptor
Gastroenterology
Immune system
Immunology
Immunotherapy
KRAS